Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
K&f Growth Acquisition II A	KFII	24. avr 2025	9.97	0.00
K&F Growth Acquisition II Unit	KFIIU	24. avr 2025	10.10	0.00
Kadant	KAI	24. avr 2025	315.71	+4.03
Kairos Pharma	KAPA	24. avr 2025	0.85	-0.81
Kaiser Aluminium	KALU	24. avr 2025	62.42	+5.94
Kaival Brands Innovations Group	KAVL	24. avr 2025	0.48	-1.02
Kaixin Holdings	KXIN	24. avr 2025	1.01	+4.66
Kala Bio	KALA	24. avr 2025	3.30	+5.77
Kalaris Therapeutics	KLRS	24. avr 2025	6.52	0.00
Kaltura	KLTR	24. avr 2025	2.07	+2.48
KalVista Pharmaceuticals	KALV	24. avr 2025	12.88	+3.45
Kamada	KMDA	24. avr 2025	6.62	+0.61
Kandi Technologies Group	KNDI	24. avr 2025	1.18	0.00
Kanzhun ADR	BZ	24. avr 2025	14.60	-0.07
Karat Packaging	KRT	24. avr 2025	25.91	+4.50
Karman	KRMN	24. avr 2025	35.13	0.00
Karooooo	KARO	24. avr 2025	42.81	+2.86
Kartoon Studios	TOON	24. avr 2025	0.54	+1.46
Karyopharm Therapeutics	KPTI	24. avr 2025	5.97	-4.78
Katapult	KPLT	24. avr 2025	7.50	-0.73
Kayne Anderson BDC	KBDC	24. avr 2025	16.28	+1.50
Kayne Anderson Energy Infrastructure Fund	KYN	24. avr 2025	11.98	+2.39
Kazia Therapeutics ADR	KZIA	24. avr 2025	3.42	+2.78
KB Financial Group ADR	KB	24. avr 2025	59.24	+0.08
KB Home	KBH	24. avr 2025	54.27	+1.50
KBR	KBR	24. avr 2025	53.50	+3.38
KBW Bank Powershares	KBWB	24. avr 2025	60.26	+2.41
KBW High Div Yield Financial Powershares	KBWD	24. avr 2025	13.33	+1.45
KBW Prem Yield Equity REIT Powershares	KBWY	24. avr 2025	15.36	-0.13
KBW Prop & Casuality Insur Powershares	KBWP	24. avr 2025	118.90	+0.06

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.